Literature DB >> 22882892

Chapter 5: Actual and counterfactual smoking prevalence rates in the U.S. population via microsimulation.

Jihyoun Jeon1, Rafael Meza, Martin Krapcho, Lauren D Clarke, Jeff Byrne, David T Levy.   

Abstract

The smoking history generator (SHG) developed by the National Cancer Institute simulates individual life/smoking histories that serve as inputs for the Cancer Intervention and Surveillance Modeling Network (CISNET) lung cancer models. In this chapter, we review the SHG inputs, describe its outputs, and outline the methodology behind it. As an example, we use the SHG to simulate individual life histories for individuals born between 1890 and 1984 for each of the CISNET smoking scenarios and use those simulated histories to compute the corresponding smoking prevalence over the period 1975-2000.
© 2012 Society for Risk Analysis.

Entities:  

Mesh:

Year:  2012        PMID: 22882892      PMCID: PMC3478148          DOI: 10.1111/j.1539-6924.2011.01775.x

Source DB:  PubMed          Journal:  Risk Anal        ISSN: 0272-4332            Impact factor:   4.000


  14 in total

1.  A model to predict the results of changes in smoking behaviour on smoking prevalence.

Authors:  John Kemm
Journal:  J Public Health Med       Date:  2003-12

2.  Predictors of quitting smoking: the NHANES I followup experience.

Authors:  W P McWhorter; G M Boyd; M E Mattson
Journal:  J Clin Epidemiol       Date:  1990       Impact factor: 6.437

3.  Analysis of lung cancer incidence in the Nurses' Health and the Health Professionals' Follow-Up Studies using a multistage carcinogenesis model.

Authors:  Rafael Meza; William D Hazelton; Graham A Colditz; Suresh H Moolgavkar
Journal:  Cancer Causes Control       Date:  2007-12-06       Impact factor: 2.506

4.  Relapse to smoking after 1 year of abstinence: a meta-analysis.

Authors:  John R Hughes; Erica N Peters; Shelly Naud
Journal:  Addict Behav       Date:  2008-06-08       Impact factor: 3.913

5.  Duration of smoking abstinence and success in quitting.

Authors:  E A Gilpin; J P Pierce; A J Farkas
Journal:  J Natl Cancer Inst       Date:  1997-04-16       Impact factor: 13.506

6.  Multistage carcinogenesis and lung cancer mortality in three cohorts.

Authors:  William D Hazelton; Mark S Clements; Suresh H Moolgavkar
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-05       Impact factor: 4.254

7.  Chapter 8: The FHCRC lung cancer model.

Authors:  William D Hazelton; Jihyoun Jeon; Rafael Meza; Suresh H Moolgavkar
Journal:  Risk Anal       Date:  2012-07       Impact factor: 4.000

8.  Lung cancer mortality is related to age in addition to duration and intensity of cigarette smoking: an analysis of CPS-I data.

Authors:  James D Knoke; Thomas G Shanks; Jerry W Vaughn; Michael J Thun; David M Burns
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-06       Impact factor: 4.254

9.  Reported prevalences of former smokers in survey data: the importance of differential mortality and misclassification.

Authors:  P J van de Mheen; L J Gunning-Schepers
Journal:  Am J Epidemiol       Date:  1994-07-01       Impact factor: 4.897

10.  Mutation and cancer: a model for human carcinogenesis.

Authors:  S H Moolgavkar; A G Knudson
Journal:  J Natl Cancer Inst       Date:  1981-06       Impact factor: 13.506

View more
  25 in total

1.  Chapter 6: Lung cancer in never smokers: epidemiology and risk prediction models.

Authors:  William J McCarthy; Rafael Meza; Jihyoun Jeon; Suresh H Moolgavkar
Journal:  Risk Anal       Date:  2012-07       Impact factor: 4.000

2.  Lung cancer detectability by test, histology, stage, and gender: estimates from the NLST and the PLCO trials.

Authors:  Kevin Ten Haaf; Joost van Rosmalen; Harry J de Koning
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-10-13       Impact factor: 4.254

3.  Study protocol for a telephone-based smoking cessation randomized controlled trial in the lung cancer screening setting: The lung screening, tobacco, and health trial.

Authors:  Kathryn L Taylor; Danielle E Deros; Shelby Fallon; Jennifer Stephens; Emily Kim; Tania Lobo; Kimberly M Davis; George Luta; Jinani Jayasekera; Rafael Meza; Cassandra A Stanton; Raymond S Niaura; David B Abrams; Brady McKee; Judith Howell; Michael Ramsaier; Juan Batlle; Ellen Dornelas; Vicky Parikh; Eric Anderson
Journal:  Contemp Clin Trials       Date:  2019-05-23       Impact factor: 2.226

4.  Patterns of birth cohort-specific smoking histories, 1965-2009.

Authors:  Theodore R Holford; David T Levy; Lisa A McKay; Lauren Clarke; Ben Racine; Rafael Meza; Stephanie Land; Jihyoun Jeon; Eric J Feuer
Journal:  Am J Prev Med       Date:  2014-02       Impact factor: 5.043

5.  A Decision Analysis of Follow-up and Treatment Algorithms for Nonsolid Pulmonary Nodules.

Authors:  Mark M Hammer; Lauren L Palazzo; Andrew L Eckel; Eduardo M Barbosa; Chung Yin Kong
Journal:  Radiology       Date:  2018-11-20       Impact factor: 11.105

6.  Should Never-Smokers at Increased Risk for Lung Cancer Be Screened?

Authors:  Kevin Ten Haaf; Harry J de Koning
Journal:  J Thorac Oncol       Date:  2015-09       Impact factor: 15.609

7.  Comparative analysis of 5 lung cancer natural history and screening models that reproduce outcomes of the NLST and PLCO trials.

Authors:  Rafael Meza; Kevin ten Haaf; Chung Yin Kong; Ayca Erdogan; William C Black; Martin C Tammemagi; Sung Eun Choi; Jihyoun Jeon; Summer S Han; Vidit Munshi; Joost van Rosmalen; Paul Pinsky; Pamela M McMahon; Harry J de Koning; Eric J Feuer; William D Hazelton; Sylvia K Plevritis
Journal:  Cancer       Date:  2014-02-27       Impact factor: 6.860

8.  Chapter 8: The FHCRC lung cancer model.

Authors:  William D Hazelton; Jihyoun Jeon; Rafael Meza; Suresh H Moolgavkar
Journal:  Risk Anal       Date:  2012-07       Impact factor: 4.000

9.  Chapter 12: Yale lung cancer model.

Authors:  Theodore R Holford; Keita Ebisu; Lisa McKay; Cheongeun Oh; Tongzhang Zheng
Journal:  Risk Anal       Date:  2012-07       Impact factor: 4.000

10.  Chapter 4: Development of the counterfactual smoking histories used to assess the effects of tobacco control.

Authors:  Theodore R Holford; Lauren Clark
Journal:  Risk Anal       Date:  2012-07       Impact factor: 4.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.